Co-Diagnostics (CODX) Q3 2020 Earnings Report

1,692 Followers

CODX Q3 2020 EPS Results

Actual EPS$0.53

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$0.10

Actual Revenue$21.82M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+52559.06%

QuarterQ3 2020

Date11/16/2020

TimeAfter Close

Conference CallMonday, November 16, 2020

CODX Upcoming Earnings

Co-Diagnostics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-1.25 / -	-4.8	―
Aug 13, 2026	2026 (Q2)	- / -1.46	-6.9	78.84% (+5.44)
May 14, 2026	2026 (Q1)	- / -4.06	-7.2	43.61% (+3.14)
Mar 31, 2026	2025 (Q4)	-3.60 / -4.06	-7.2	43.61% (+3.14)
Nov 13, 2025	2025 (Q3)	-5.70 / -4.80	-9.6	50.00% (+4.80)
Aug 14, 2025	2025 (Q2)	-7.50 / -6.90	-7.5	8.00% (+0.60)
May 08, 2025	2025 (Q1)	-8.10 / -7.20	-9.3	22.58% (+2.10)
Mar 27, 2025	2024 (Q4)	-10.20 / -10.80	-14.82	27.13% (+4.02)
Nov 07, 2024	2024 (Q3)	-9.90 / -9.60	-6	-60.00% (-3.60)
Aug 08, 2024	2024 (Q2)	-10.20 / -7.50	-9.3	19.35% (+1.80)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed